Colorectal Peritoneal Metastases State of Art

Authors

  • Spiliotis John Director and Chairman, 4th Department of Surgery and Surgical Oncology European Interbalkan Medical Center, Thessaloniki Greece Author

DOI:

https://doi.org/10.47363/JGHR/2023(4)158

Keywords:

Colorectal Peritoneal , Hyperthermic Intra-Operative Intraperitoneal Chemotherapy (HIPEC), Peritoneal Cancer Growth File

Abstract

The presence of peritoneal metastasis (PM) in patients with colorectal cancer (CRC) is associated with an extremely poor prognosis. Recent developments in the field of treatment including new drugs, translational research for new molecules offer a future plan to achieved improved of Survival. On the other hand, numerous clinical trials regarding the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy have now opened new doors in peritoneal metastasis treatment. This review presents all the controversial data and options regarding this approach. 

Author Biography

  • Spiliotis John, Director and Chairman, 4th Department of Surgery and Surgical Oncology European Interbalkan Medical Center, Thessaloniki Greece

    Director and Chairman, 4th Department of Surgery and Surgical Oncology European Interbalkan Medical Center, Thessaloniki Greece

Downloads

Published

2023-12-18

Issue

Vol. 4 No. 4 (2023): Volume 4 Issue 4

Section

Articles